When baseline activity in a neuronal network is modified by external challenges, a 3 set of mechanisms is prompted to homeostatically restore activity levels. These 4 homeostatic mechanisms are thought to be profoundly important in the maturation of the 5 network. We have previously shown that 2-day blockade of either excitatory GABAergic 6 or glutamatergic transmission in the living embryo transiently blocks the movements 7 generated by spontaneous network activity (SNA) in the spinal cord. However, by 2 hours 8 of persistent receptor blockade embryonic movements begin to recover, and by 12 hours 9
Introduction.
Recent work has focused on the mechanisms that allow networks to 48 homeostatically maintain their activity levels in the face of various perturbations (1) (2) (3) . 49
Typically, activity is altered for 24 hours or more and compensatory changes in intrinsic 50 cellular excitability and/or synaptic strength (synaptic scaling) are observed following the 51 perturbation. While most of the work has been carried out in vitro, homeostatic 52 mechanisms have also been observed in vivo in the spinal cord (4-6), hippocampal (7), 53 auditory (8) and visual systems (9, 10). We have studied homeostatic plasticity in the 54 chick embryo spinal cord, which expresses a spontaneously occurring network activity 55 (SNA) that drives embryonic movements (11, 12) . SNA likely occurs in all developing 56 circuits shortly after synaptic connections form. In the embryonic spinal cord this activity 57 is a consequence of the highly excitable nature of the nascent synaptic circuit where 58
GABAergic neurotransmission is depolarizing and excitatory during early development 59 (11-16). Spinal SNA is known to be important in motoneuron axonal pathfinding (17), and 60 for proper muscle and joint development (18) (19) (20) (21) (22) (23) . 61
The embryonic spinal cord provides an exceptional model of homeostasis. The 62 isolated embryonic spinal preparation exhibits SNA in vitro, which is transiently blocked 63 by either glutamatergic or GABAergic receptor (GABAR) antagonists, but within hours is 64 homeostatically restored in the presence of that antagonist (24, 25) . As in the isolated 65 cord in vitro, SNA-generated embryonic movements in vivo also exhibit a homeostatic 66 recovery following blockade of either of the main excitatory neurotransmitter receptors. 67
When GABAA or glutamate receptor antagonists were injected into the egg at embryonic 68 day 8 (E8), SNA-driven embryonic movements were abolished for 1-2 hours, but then 69 homeostatically recovered to control levels 12 hours after the onset of pharmacological 70 blockade of either transmitter (26). This provided us with the opportunity to assess 71 mechanisms that contribute to the homeostasis of activity in the living system as it actually 72 recovers. Although we initially thought that similar mechanisms would drive the recovery 73 of embryonic activity following injection of either antagonist, we determined that 74 compensatory changes in intrinsic excitability and synaptic scaling were only observed 75 following blockade of GABAA receptors, not glutamate receptors. Further, scaling was not 76 observed by the time SNA-generated movements had fully recovered (12 hour 77 GABAergic block). While compensatory changes in voltage-gated conductances were 78 observed by this 12 hour time point, it was unknown if they occurred by 2 hours when the 79 movements first start to recover (5), or if other mechanisms may be in place to initiate this 80 recovery. In addition, the recovery of embryonic movements following glutamatergic 81 blockade was very similar to that after GABAR blockade, but the mechanisms that drove 82 this recovery remained completely unclear. 83
We had not examined the possibility that compensatory changes in cell excitability 84 and/or scaling were occurring at the onset and throughout the recovery process in 85 motoneurons. In fact, very few studies have compared the expression of presumptive 86 homeostatic mechanisms with the timing of the homeostatic recovery of activity, yet we 87 would expect that some of these mechanisms would be expressed at the very onset of 88 the recovery process. Further, we had only focused on motoneurons in these previous 89 studies, and had little knowledge about compensations that may be occurring in the 90 interneurons that contribute to the drive of SNA. Therefore, we set out to identify the 91 mechanisms that are expressed during the actual period of homeostatic recovery of 92 embryonic activity in vivo. We find a previously unrecognized mechanism of homeostatic 93 intrinsic plasticity where fast changes in resting membrane potential (RMP) bring both 94 interneurons and motoneurons closer to action potential threshold. The NaHCO3, 3 KCl, 1 MgCl2, and 3 CaCl2; constantly bubbled with a mixture of 95% O2-106 5% CO2 to maintain oxygenation and pH around 7.3 (for a full description, see (4)). After 107 the dissection, the cord was allowed to recover for at least 6 hrs in Tyrode's solution at 108 18°C. The cord was then transferred to a recording chamber and continuously perfused 109 with Tyrode's solution heated to 27°C to allow for the expression of bouts of SNA with a 110 consistent frequency. 111 112
Electrophysiology. 113
Whole-cell current clamp recordings were made from spinal motoneurons localized in 114 lumbosacral segments 1-3 and were identified by their lateral position in the ventral cord.
Recordings were also made from interneurons in the same segments but these were 116 identified by their more medial position in the ventral cord. Patch Clamp tight seals (>2 117 G) were obtained using electrodes pulled from thin-walled borosilicate glass (World 118
Precision Instruments, Inc) in two stages, using a P-87 Flaming/Brown micropipette puller 119 (Sutter Instruments) to obtain resistances between 5 and 10 M. Once whole-cell 120 configuration was achieved, voltage clamp was maintained for a period of 5 minutes to 121 allow stabilization before switching to current clamp configuration. In some cases, whole 122 cell voltage clamp recordings were also made from motoneurons and interneurons in 123 order to acquire miniature postsynaptic currents (mPSCs) and these recordings were 124 started after the 5 minute stabilization period. Series resistance during recording varied 125 from 15 to 20 MΩ among different neurons and was not compensated. AMPA and GABA 126 mPSCs were separated by their decay kinetics as described previously (Gonzalez-Islas 127 and Wenner, 2006) . The mPSCs were acquired on an Axopatch 200B patch clamp 128 amplifier (Molecular Devices), digitized on-line using PClamp 10 (Molecular Devices), and 129 analyzed using Minianalysis software (Synaptosoft). Bar charts and associated average 130 values were obtained by determining an average mPSC amplitude for each cell (variable 131 number of mPSCs/cell, 5pA cutoff), and then calculating the average of all cells. 132
Recordings in current clamp were terminated whenever significant increases in input 133 resistance (>20%) occurred. For voltage clamp experiments, recordings were terminated 134 whenever significant increases in series resistance (> 20%) occurred. Both current and 135 voltage clamp recordings were acquired using an AxoPatch 200B amplifier controlled by 136 pClamp 10.1 software (Molecular Devices). The intracellular patch solution for both 137 current and voltage clamp recordings contained the following (in mM): 5 NaCl, 100 K-gluconate, 36 KCl, 10 HEPES, 1.1 EGTA, 1 MgCl2, 0.1 CaCl2, 1 Na2ATP, and 0.1 MgGTP; 139 pipette solution osmolarity was between 280 and 300 mOsm, and pH was adjusted to 7.3 140 with KOH. Standard extracellular recording solution was Tyrode's solution (see above), 141 constantly bubbled with a mixture of 95% O2-5% CO2. For embryos treated with saline or 142 gabazine in ovo, a step protocol (1s, in 1pA increments) was employed to obtain 143 rheobase, threshold voltage, and f-I relationships. To measure short-term changes in 144 rheobase and threshold voltage following in vitro application of gabazine, a ramp protocol 145 (from 0 to 200 pA; 1.2 s) was used ( Figure 1A) . 146
147
In ovo drug injections. 148
A window in the shell of the egg was opened to allow monitoring of chick embryo 149 movements and drug application 6 or 12 hrs before isolating the spinal cord at E10. 50 μl 150 of a 10 mM gabazine solution was applied onto the chorioallantoic membrane of the chick 151 embryo to a final concentration of 10µM, assuming a 50 ml egg volume. 152 153
Immunoblots. 154
The ventral half of the lumbosacral spinal cords were homogenized in RIPA buffer 155 containing protease and phosphatase inhibitors. Samples were then centrifuged to 156 remove cell debris. Protein concentration was quantitated using BCA reagent (Pierce). 157
Samples were separated on 4-15% SDS-PAGE, and blotted to a nitrocellulose 158 membrane. The primary antibodies against Nav 
Changes in motoneuron excitability observed during the homeostatic recovery of 180

SNA. 181
In the embryonic spinal cord episodes of SNA are triggered through spiking of 182 motoneurons that activate Renshaw cells (class of interneuron, (28)), which then recruit the rest of the network (29). Given the importance and accessibility of motoneurons in the 184 initiation of SNA we have previously examined compensatory changes following 185
GABAergic blockade in this cell type. In those studies we have shown that spinal 186 motoneuron voltage-gated Na + and K + channel currents were altered following 12 hours 187 of GABAergic blockade, after embryonic movements have homeostatically recovered (5). 188
In order to determine if these changes actually contribute to the recovery, we assessed 189 cellular excitability in motoneurons during the period that the SNA-driven movements 190 were actually recovering, but before complete recovery was achieved. First, we tested 191 whether cellular excitability had increased during the period that movements were in the 192 process of homeostatically recovering, following 6 hours of gabazine treatment (10µM) in 193 ovo. We isolated the spinal cord following treatment, and recorded whole cell in current 194 clamp from motoneurons no longer in the presence of gabazine. We assessed threshold 195 current (rheobase) and the voltage deflection produced by this current (threshold voltage, 196 Table 1 ). Threshold current and voltage was reduced, compared to controls. As 197 observed previously, threshold current was reduced following 12 hours of gabazine 198 treatment in ovo ( Figure 1 ). We also assessed excitability by giving current steps and 199 plotting this against firing frequency after either 6 or 12 hours of gabazine treatment 200 ( Figure 1F ). We saw a very strong shift toward higher excitability in the FI curve at the 6 201 hour time point, which then moved back toward pre-drug values following 12 hour 202 treatment, although cells still showed a heightened excitability compared to controls. We 203 did not observe changes in resting membrane potential or input resistance ( Figure 1D , 204 E). 205
One advantage of the earlier experiments was that the perturbation was carried 206 out in vivo. Unfortunately, in order to measure cellular excitability the cord must be 207 isolated and was given several hours to recover in the absence of gabazine before we 208 could make excitability measurements. Such a process could itself alter the excitability of 209 the cells. Therefore, in addition to the in vivo perturbations, we wanted to assess cellular 210 excitability changes in the isolated cord in vitro as SNA was recovering, but still in the 211 presence of gabazine. Control spinal cords were isolated and expressed episodes of SNA 212 in vitro at a fairly constant frequency and then gabazine (10µM) was added to bath and 213 whole cell recording of motoneurons were obtained in the presence of gabazine at 214 different points after the addition of the GABAA antagonist. Following in vitro 6 hour (4-6 215 hours) gabazine treatment, motoneuron cellular excitability was increased (Figure 2A Like the 6 hour treatment, we found that motoneuron cellular excitability was also 219 increased in the first 2 hours and from 2-4 hours of in vitro exposure to gabazine ( Figure  220 2A-B). We saw that changes in threshold voltage were between 10-17mV, and that a 221 depolarization the RMP could account for ~5mV of this change in threshold voltage. RMP 222 was reduced at 0-2, 2-4, and 4-6 hour time points, but did not reach significance in any 223 of these periods. On the other hand if we compared control RMP to gabazine-treated at 224 all time points combined, then there was a significant depolarization of RMP (p=0.03, 225 Figure 2C ). We saw no change in input resistance in any of the conditions ( Figure 2D ). 226
These results suggest that compensatory changes in motoneuron excitability occurs very 227 quickly and therefore could contribute to the recovery of SNA, and part of this shift in 228 threshold was due to a change in the RMP. 229 230 Changes in interneuron excitability occur during the recovery of SNA following 231
GABAergic blockade. 232
We wanted to determine whether these increases in cellular excitability were only 233 occurring in motoneurons, or whether this was a more general phenomenon that extends 234 to the rest of the developing motor circuitry. Thus, we assessed the possibility that spinal 235 interneurons also increased cell excitability following gabazine treatment and could 236 therefore contribute to the homeostatic recovery of SNA. Spinal neurons were targeted in 237 the more medial positions of the cord. We found that, like motoneurons, interneurons had 238 reduced threshold current and voltage (increased cellular excitability) following both 6 and 239 12 hours of gabazine treatment in ovo ( Figure 3A -B, Table 1 ). Similar increases in cellular 240 excitability were also observed in interneurons from isolated cords that were treated with 241 bath application of gabazine for 0-2, 2-4, and 4-6hrs in vitro ( Figure 3A -B, Table 1 ). 242
Because we were recording from diverse classes of spinal neurons, the results suggest 243 that various cell types alter their cellular intrinsic excitability and contribute to the recovery 244 of activity following GABAergic blockade. Importantly, interneuron RMP was significantly 245 depolarized at each of the time points ( Figure 3D ). The threshold voltage after gabazine 246 treatment (in vitro or in vivo) at any of the times was reduced by ~10-18mV. A depolarized 247 RMP could account for the change in threshold voltage following the in vitro gabazine 248 studies (11-17mV), but only partially could explain the results following 6 hour in vivo 249 gabazine treatment ( Figure 3B, D) . No changes were observed in input resistance in any 250 condition. Therefore, interneurons increased their cellular excitability after GABAergic 251 blockade similarly to motoneurons. However, interneurons achieved the increase in 252 excitability following in vitro gabazine solely through a depolarized RMP, unlike 253
motoneurons. 254
Since the changes in cellular excitability following GABAR blockade appear to be 255 expressed across multiple cell types throughout much of the cord, we ran Western blots 256 of isolated spinal cords (ventral half) and assessed 2 of the voltage-gated channels that 257 we expected could mediate this process. We reported in an earlier study (5) that 258 gabazine-induced changes were observed in voltage-gated Na + and K + channels. In that 259 study we saw TTX-sensitive voltage-gated Na + channel currents were increased. 260
Therefore, we assessed the levels of Nav1.2, an alpha subunit of the voltage-gated Na + 261 channel, which had been shown to be expressed early in the development of the 262 embryonic chick (30). We found that following 12 hour gabazine treatment in ovo, Nav1.2 263 expression was increased (172.4±14.8%, p ≤ 0.05), but not after 6 hour treatment (105.3 264 ± 5.3%, Figure 4 ). Further, we had observed that currents of the A-type transiently-265 activated K + channel (IA) and the calcium-dependent K + channel (IK(Ca)) were both 266 decreased following gabazine treatment (5). Here, we show that expression of Kv4.2 267 (mediates the A-type K + channel in chick embryo (31)) is down regulated following 12 268 hour gabazine treatment (54.5 ± 2.5%, p ≤ 0.05), but not after 6 hours (104.2 ± 17.2%, 269 were not observed until 48 hours, but voltage-gated conductance changes were triggered 278 by 12 hours (5, 26). More recently we have determined that simply reducing GABAAR 279 activation due to spontaneous miniature release of GABA vesicles (spontaneous 280
GABAergic transmission) was sufficient to trigger upscaling (32). Therefore, we tested 281 the possibility that the fast changes in cellular excitability observed in the current study 282 were also mediated by reduced spontaneous miniature GABAergic neurotransmission. 283
As in previous studies we took advantage of the nicotinic antagonist DHβE, which reduces 284 spontaneous GABA release, to test this possibility. Whole cell recordings from 285 motoneurons were obtained before and 2 hours after DHβE application in vitro. We did 286 not find any differences in cellular excitability following reduction of GABA release by 287 DHβE (Figure 5 ). Therefore, unlike the trigger for synaptic scaling, the compensatory 288 changes in cellular excitability in the first hours of GABAergic blockade were not mediated 289 by changes in spontaneous GABAergic transmission. 290 291
Synaptic scaling does not contribute to the homeostatic recovery of SNA-292 generated movements. 293
Previously we showed that AMPAergic and GABAergic upscaling were not 294 observed in chick embryo motoneurons following 12 hour gabazine treatment in ovo. 295
However, it remained possible that interneurons experienced scaling and contributed to 296 the homeostatic recovery of SNA. We had never directly assessed mPSC scaling in 297 interneurons previously, so it was possible that scaling in spinal interneurons occurred in 298 the first hours of gabazine treatment. However, following 6hrs of gabazine treatment in 299 ovo we found no increase in AMPA mPSC amplitude in interneurons ( Figure 6A ). We 300 would not have expected GABAergic scaling to contribute to the recovery of movements 301 as we were blocking GABAA receptors. Regardless, we examined the possibility that 302
GABAergic blockade triggered GABAergic scaling in interneurons as we previously found 303 slight increases in interneuronal Cl -, which mediated GABAergic scaling following 24 304 hours of gabazine treatment in ovo (33, 34). We did not see any change in GABA mPSC 305 amplitude in interneurons following 6hr gabazine treatment in ovo ( Figure 6A ). The results 306
show that 6 hour gabazine treatment did not trigger either AMPAergic or GABAergic 307 scaling in interneurons, and so would not contribute to the homeostatic recovery of activity 308
levels. 309
We have reported that scaling is not triggered in motoneurons after 12 hours of 310 gabazine treatment, but had not checked if it was transiently expressed in the first hours 311 as the network recovered as has been described in cultured neurons (35, 36). We 312 therefore tested for AMPAergic and GABAergic scaling in motoneurons following 6 hours 313 of gabazine treatment in ovo. We found that AMPAergic and GABAergic mPSC amplitude 314 was no different than controls ( Figure 6B ). These findings showed that synaptic scaling 315 of AMPAergic mPSCs in different spinal populations could not have contributed to the 316 recovery of SNA or the movements it drives following GABAergic blockade. Finally, there 317 was no compensatory increase in mPSC frequency in interneurons ( Figure 6C ), or motoneurons ( Figure 6D ). In fact, we found a significant reduction in GABAergic mPSC 319 frequency. 320 321 Recovery of embryonic movements following glutamatergic blockade is mediated 322 by fast changes in resting membrane potential. 323
Previously, we had carried out experiments where a similar homeostatic recovery 324 of embryonic movements was observed following glutamatergic blockade, instead of 325 GABAergic blockade. Following GABAergic or glutamatergic blockade movements 326 recovered in around 12 hours, but after 12 hours of glutamatergic blockade we did not 327 see synaptic scaling or homeostatic changes in intrinsic excitability. However, we never 328 looked at earlier time points in the presence of glutamatergic antagonists to see if there 329
were changes in intrinsic excitability. Therefore, we isolated spinal cords and tested for 330 compensatory changes in intrinsic excitability from 0-6 hours of CNQX (20µM)/APV 331 (50µM) application in vitro in the continued presence of the antagonists. We observed 332 that motoneurons did indeed express reductions in threshold current and voltage (15-333 20mV) in the first 6 hours of drug application ( Figure 7A-B ). As following GABAergic 334 blockade, the reduction in threshold voltage was reasonably well matched by a similar 335 depolarization of resting membrane potential (12-14mV), and no change in input 336 resistance was seen ( Figure 7C-D) . Similarly interneurons showed the same response to 337 glutamatergic blockade, a fast increase in threshold voltage (~15mV) mediated by a 338 GABAergic blockade in vitro and following 6 and 12 hours of transmitter blockade in vivo 361 that were not completely explained by changes in RMP. These changes were likely to be 362 similar to the previously described changes in voltage-gated conductances associated 363 with homeostatic intrinsic plasticity following 12 hours of GABAergic blockade (5).
Changes in protein levels of 2 previously implicated voltage-gated ion channels were only 365 observed at 12 hours, although not at 6 hours of in vivo gabazine treatment (Figure 4) . 366
Therefore, these gabazine-induced changes in intrinsic plasticity could contribute to the 367 recovery of activity by 12 hours along with changes in RMP. Interestingly, following 368 glutamatergic blockade, the changes in threshold voltage (~15mV) could be completely 369 explained by changes in RMP (~15mV, Figure 7 hand, none of these studies followed the RMP before and immediately after the 388 perturbation as we have done in the current study. Therefore, changes in RMP may have 389 occurred in these previous studies but over the duration and/or after removal of the 390 perturbation no change was detected. An exception to this was described following a fairly 391 severe perturbation (2 week exposure to 15mM KCl), where a homeostatic 392 hyperpolarization of RMP was observed in cultured hippocampal neurons (42). 393 394
Conductances that contribute to the RMP and the timing of homeostatic changes. 395
Several different ion channels exhibit activation at subthreshold potentials and thus 396 contribute to setting the RMP including multiple kinds of K + channels (Ia, Ikir, Ileak) (43, 397 44), hyperpolarization-activated cationic channels (Ih) (45, 46), low-threshold calcium 398 channels (47), persistent sodium currents (NaPIC) (48, 49), and leak sodium channels 399 (NALCN) (50, 51). In addition, ongoing synaptic conductances can also influence the 400 RMP (52, 53). Previous work has shown that blocking GABARs by direct application of a 401 GABA receptor antagonist onto a chick embryo spinal cord preparation causes an acute 402 hyperpolarization in spinal neurons that can be as large as 10mV, suggesting a significant 403 tonic GABAergic depolarizing current (54). The effect of acute application of GABAergic 404 antagonist onto the cord (54) is in the opposite direction (hyperpolarizing) compared to 405 the current studies finding that bath application of gabazine leads to a depolarization of 406 RMP in the first hours of drug exposure. The current study is the only one we are aware 407 of that follows RMP before and throughout the first hours of the perturbation, and may 408 explain why this form of homeostatic intrinsic plasticity has not been previously reported. 409
Mechanisms of homeostatic changes in RMP. 411
What is a potential trigger for these homeostatic changes in RMP? Previously we 412 have shown that homeostatic synaptic scaling is triggered following 48 hour block of 413
GABAergic transmission (26) and compensatory changes in voltage-gated ion channel 414 conductances by 12 hours of GABAR block (5). In fact, we have also shown that merely 415 altering GABAR activation due to spontaneous release of GABA vesicles can fully trigger 416 synaptic scaling. However, compensatory changes in RMP were not so reliant on GABAR 417 activation. Fast changes in RMP are not triggered by altering the frequency of 418 spontaneous vesicle-mediated GABAR activation ( Figure 5 ). Further, these changes can 419 also be triggered by reduced glutamatergic receptor activation where GABAR activation 420 is intact. GABAergic or glutamatergic receptor blockade both trigger compensatory 421 changes in RMP and exhibit a temporally similar recovery of movements. Therefore, the 422 most straightforward explanation for the trigger of homeostatic changes in RMP would be 423 the reduction in network activity caused by blocking either glutamatergic or GABAergic 424 receptors. Compensatory changes in RMP driven by network activity would fit nicely with 425 a direct feedback mechanism where activity is regulated by changes in activity. 426
There are two general mechanisms that could mediate the quick homeostatic 427 changes in RMP. A commonly described mechanism underlying a change in RMP 428 involves a change in some channel conductance (e.g. K + channels). While this is certainly 429 a possibility, we did not see a change in input resistance. Therefore, multiple channel 430 conductances would need to change in an orchestrated manner such that total 431 conductance remained unchanged. 432 A potentially more plausible mechanism for our observations would involve a 433 change in the function of the Na + /K + ATPase. Previous studies are consistent with this 434 possibility. First, it has been shown that temperature influences spike frequency through 435 adjustments in the resting membrane potential of invertebrate neurons, and this is 436 mediated by an alteration of the electrogenic Na + /K + ATPase (55-57). Next, work in the 437 spinal cord of xenopus and neonatal mice, as well as in motoneurons of the fly larva, 438
show that bursts of spiking activity expressed in these systems lead to an increase in 439 intracellular Na + , that is necessary to activate an isoform of the Na + /K + ATPase that is not 440 active at baseline Na + levels. The Na + -dependent activation of this Na + /K + ATPase 441 produces a hyperpolarizing current due to the electrogenic nature of the pump that has 442 been called an ultra slow afterhyperpolarization (usAHP) (58-61). This hyperpolarizing 443 current is maintained for up to a minute. SNA in the chick embryo spinal preparation 444 experiences a very similar usAHP after episodes of SNA. Further, we have established 445 that embryonic spinal neurons have very high Na + concentrations at baseline (62). 446
Therefore, it is possible that Na + levels constitutively activate this Na + /K + ATPase and 447 when SNA is blocked for many minutes by glutamatergic or GABAergic antagonists, Na + 448 levels eventually are reduced to a point that pump activity is minimized and the 449 hyperpolarizing current abates, thus depolarizing the RMP. 450
Alternatively, a downregulation of the Na + /K + ATPase activity could produce the 451 depolarization of RMP through a weakening of the K + gradient. In fact, this has been 452 described following chronic disuse of muscle fibers (63-65). Consistent with a plasticity 453 of the Na + /K + ATPase, it is clear that Na + , as well as Cl -, concentration is dynamically regulated during development in embryonic spinal motoneurons, and this is consistent 455 with the idea that K + will also be dynamically regulated during this period (33, 62, 66) . 37.0 ± 6.9 p ≤ 0.01
